Table 2. The histopathological and histomorphometric findings of Weeks 2 and 4 control and cephalexin groups.
| Variables | Week 2 | Week 4 | p value | ||
| Median | Min-Max | Median | Min-Max | ||
| Histological healing score | |||||
| Control | 4.0 | 3.0-4.0 | 7.0 | 6.0-7.0 | 0.002 |
| Cephalexin | 3.5 | 2.0-5.0 | 7.0 | 6.0-7.0 | 0.002 |
| p value | 0.517 | 0.677 | |||
| Inflammation | |||||
| Control | 3.0 | 2.0-3.0 | 1.5 | 1.0 - 2.0 | 0.010 |
| Cephalexin | 3.0 | 2.0-3.0 | 1.0 | 1.0-2.0 | 0.008 |
| p value | 0.933 | 0.680 | |||
| Cartilaginous callus area/total callus area (%) | |||||
| Control | 29.37 | 24.92-48.78 | 50.36 | 24.68-75.09 | 0.096 |
| Cephalexin | 42.17 | 25.84-52.30 | 50.64 | 30.79-95.05 | 0.385 |
| p value | 0.099 | 0.953 | |||
| Total callus diameter/femoral diameter (%) | |||||
| Control | 59.42 | 46.71-71.35 | 53.44 | 45.18-66.88 | 0.353 |
| Cephalexin | 53.77 | 42.51-73.37 | 51.24 | 42.81-58.38 | 0.325 |
| p value | 0.277 | 0.438 | |||
| BMD: Bone mineral density. | |||||